Literature DB >> 22383744

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5--comment.

Jürgen Thiele1, Attilio Orazi, Hans Michael Kvasnicka, Vito Franco, Emanuela Boveri, Umberto Gianelli, Heinz Gisslinger, Francesco Passamonti, Ayalew Tefferi, Tiziano Barbui.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22383744      PMCID： PMC3291579          DOI： 10.3324/haematol.2011.061432

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  11 in total

1.  The significance of bone marrow biopsy and JAK2V617F mutation in the differential diagnosis between the "early" prepolycythemic phase of polycythemia vera and essential thrombocythemia.

Authors:  Umberto Gianelli; Alessandra Iurlo; Claudia Vener; Alessia Moro; Elisa Fermo; Paola Bianchi; Daniela Graziani; Franca Radaelli; Guido Coggi; Silvano Bosari; Giorgio Lambertenghi Deliliers; Alberto Zanella
Journal:  Am J Clin Pathol       Date:  2008-09       Impact factor: 2.493

Review 2.  Prodromal myeloproliferative neoplasms: the 2008 WHO classification.

Authors:  Hans Michael Kvasnicka; Juergen Thiele
Journal:  Am J Hematol       Date:  2010-01       Impact factor: 10.047

3.  Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification.

Authors:  Jürgen Thiele; Hans Michael Kvasnicka; Leonhard Müllauer; Veronika Buxhofer-Ausch; Bettina Gisslinger; Heinz Gisslinger
Journal:  Blood       Date:  2011-03-29       Impact factor: 22.113

4.  European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis.

Authors:  Thomas Buhr; Konnie Hebeda; Vassiliki Kaloutsi; Anna Porwit; Jon Van der Walt; Hans Kreipe
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

5.  Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis.

Authors:  Maud Brousseau; Elsa Parot-Schinkel; Marie-Pierre Moles; Françoise Boyer; Mathilde Hunault; Marie-Christine Rousselet
Journal:  Histopathology       Date:  2010-05       Impact factor: 5.087

6.  Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia.

Authors:  Jurgen Thiele; Hans Michael Kvasnicka; Volker Diehl
Journal:  Acta Haematol       Date:  2005       Impact factor: 2.195

Review 7.  The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.

Authors:  James W Vardiman; Jüergen Thiele; Daniel A Arber; Richard D Brunning; Michael J Borowitz; Anna Porwit; Nancy Lee Harris; Michelle M Le Beau; Eva Hellström-Lindberg; Ayalew Tefferi; Clara D Bloomfield
Journal:  Blood       Date:  2009-04-08       Impact factor: 22.113

8.  Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelofibrosis: recommendations from an ad hoc international expert panel.

Authors:  Ayalew Tefferi; Juergen Thiele; Attilio Orazi; Hans Michael Kvasnicka; Tiziano Barbui; Curtis A Hanson; Giovanni Barosi; Srdan Verstovsek; Gunnar Birgegard; Ruben Mesa; John T Reilly; Heinz Gisslinger; Alessandro M Vannucchi; Francisco Cervantes; Guido Finazzi; Ronald Hoffman; D Gary Gilliland; Clara D Bloomfield; James W Vardiman
Journal:  Blood       Date:  2007-05-08       Impact factor: 22.113

9.  Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens.

Authors:  Thomas Buhr; Guntram Büsche; Harald Choritz; Florian Länger; Hans Kreipe
Journal:  Am J Clin Pathol       Date:  2003-01       Impact factor: 2.493

10.  Bone marrow pathology in essential thrombocythemia: interobserver reliability and utility for identifying disease subtypes.

Authors:  Bridget S Wilkins; Wendy N Erber; David Bareford; Georgina Buck; Keith Wheatley; Clare L East; Beverley Paul; Claire N Harrison; Anthony R Green; Peter J Campbell
Journal:  Blood       Date:  2007-09-20       Impact factor: 22.113
View more
  3 in total

Review 1.  WHO classification of myeloproliferative neoplasms (MPN): A critical update.

Authors:  Hans Michael Kvasnicka
Journal:  Curr Hematol Malig Rep       Date:  2013-12       Impact factor: 3.952

2.  Thrombosis in essential thrombocytemia and early/prefibrotic primary myelofibrosis: the role of the WHO histological diagnosis.

Authors:  Serena Rupoli; Gaia Goteri; Paola Picardi; Giorgia Micucci; Lucia Canafoglia; Anna Rita Scortechini; Irene Federici; Federica Giantomassi; Lidia Da Lio; Antonio Zizzi; Elisa Honorati; Pietro Leoni
Journal:  Diagn Pathol       Date:  2015-04-16       Impact factor: 2.644

Review 3.  Circulating Cytokine Levels as Markers of Inflammation in Philadelphia Negative Myeloproliferative Neoplasms: Diagnostic and Prognostic Interest.

Authors:  Julie Mondet; Kais Hussein; Pascal Mossuz
Journal:  Mediators Inflamm       Date:  2015-10-07       Impact factor: 4.711
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.